EGFR ANTI-EGFR ANTIBODY DRUG CONJUGATES

본 발명은 Bcl-xL을 저해하는 항-상피 성장 인자 수용체(EGFR) 항체 약물 콘쥬게이트(ADC)(조성물 및 상기 ADC의 사용 방법을 포함함)에 관한 것이다: JPEGpat00533.jpg9772. The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs....

Full description

Saved in:
Bibliographic Details
Main Authors BOGHAERT ERWIN R, SOUERS ANDREW J, PHILLIPS ANDREW C, JUDD ANDREW S, BRUNCKO MILAN
Format Patent
LanguageEnglish
Korean
Published 14.03.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:본 발명은 Bcl-xL을 저해하는 항-상피 성장 인자 수용체(EGFR) 항체 약물 콘쥬게이트(ADC)(조성물 및 상기 ADC의 사용 방법을 포함함)에 관한 것이다: JPEGpat00533.jpg9772. The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs.
Bibliography:Application Number: KR20237007108